• OPEN AN ACCOUNT
Indian Indices
Sensex
74,529.08 -329.91
( -0.44%)
Global Indices
Nasdaq
52,073.35 369.71
(0.72%)
Dow Jones
7,785.28 113.78
(1.48%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,737.46 78.33
(0.73%)
Forex
USD-INR
95.99 0.12
(0.12%)
EUR-INR
110.24 0.24
(0.22%)
GBP-INR
128.54 0.36
(0.28%)
JPY-INR
0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

Bhansali Engineering Polymers Ltd
Industry :  Petrochemicals
BSE Code
ISIN Demat
Book Value()
500052
INE922A01025
43.4759078
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BEPL
16.03
3187.88
EPS(TTM)
Face Value()
Div & Yield %
7.99
1
3.12
 

InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.